MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. 2014

Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Dongfang Road, No. 1630, Shanghai 200127, China.

MicroRNA-24 (miR-24) may be involved in neoplastic process; however, the role of this microRNA in the hepatocellular carcinoma (HCC) related to aflatoxin B1 (AFB1) has not been well elaborated. Here, we tested miR-24 expression in 207 pathology-diagnosed HCC cases from high AFB1 exposure areas and HCC cells. We found that miR-24 was upregulated in HCC tumor tissues relative to adjacent noncancerous tissue samples, and that the high expression of miR-24 was significantly correlated with larger tumor size, higher microvessel density, and tumor dedifferentiation. Additionally, this microRNA overexpression modified the recurrence-free survival (relative hazard ratio [HR], 4.75; 95% confidence interval [CI], 2.66-8.47) and overall survival (HR = 3.58, 95% CI = 2.34-5.46) of HCC patients. Furthermore, we observed some evidence of joint effects between miR-24 and AFB1 exposure on HCC prognosis. Functionally, miR-24 overexpression progressed tumor cells proliferation, inhibited cell apoptosis, and developed the formation of AFB1-DNA adducts. These results indicate for the first time that miR-24 may modify AFB1-related HCC prognosis and tumorigenesis.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009183 Mycotoxins Toxic compounds produced by FUNGI. Fungal Toxins,Mycotoxin,Toxins, Fungal
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016604 Aflatoxin B1 A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1. Aflatoxin B(1),Aflatoxin B,Aflatoxin B1 Dihydrochloride, (6aR-cis)-Isomer,Aflatoxin B1, (6aR-cis)-Isomer, 14C-Labeled,Aflatoxin B1, (6aR-cis)-Isomer, 2H-Labeled,Aflatoxin B1, (6aR-cis)-Isomer, 3H-Labeled,Aflatoxin B1, cis(+,-)-Isomer,HSDB-3453,NSC-529592,HSDB 3453,HSDB3453,NSC 529592,NSC529592

Related Publications

Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
January 2013, Gastroenterology research and practice,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
September 1980, Tropical and geographical medicine,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
October 2017, Oncotarget,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
June 2016, Molecular carcinogenesis,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
August 2003, Cancer research,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
January 2016, Oxidative medicine and cellular longevity,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
December 2000, Experimental lung research,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
January 2012, Annals of hepatology,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
April 2018, Oncology letters,
Yi-Xiao Liu, and Xi-Dai Long, and Zhi-Feng Xi, and Yun Ma, and Xiao-Ying Huang, and Jin-Guang Yao, and Chao Wang, and Tian-Yu Xing, and Qiang Xia
February 2016, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!